Consonance Capital Partners Closes $1.35 Billion Healthcare Equity Fund III
TL/DR –
US-based healthcare private equity firm, Consonance Capital Partners announced the closing of its Consonance Private Equity III, L.P. (Fund III) with commitments totaling $1.35 billion. The final close on Fund III was completed in under four months and was heavily oversubscribed. The fund will focus on investments in lower and middle market US healthcare companies, consistent with its predecessor funds.
US Healthcare Equity Firm ‘Consonance Capital Partners’ Closes Fund III
US-based healthcare private equity firm, Consonance Capital Partners (Consonance), announced a significant milestone in their fundraising efforts with the closing of Consonance Private Equity III, L.P. (Fund III), amassing total commitments of US$1.35 billion under four months. The fund reached its hard cap swiftly due to a heavily oversubscribed process.
The firm’s consistent investment strategy will continue with Fund III, focusing on lower and middle market US healthcare companies, further solidifying Consonance’s role as a leading player in healthcare private equity investments.
In the complex transaction, Consonance was represented by a team from Latham & Watkins LLP, led by Investment Funds partners Andrea Schwartzman and Erin Bergey. Counseling was also provided on US tax matters by partner Greg Hannibal, and on funds regulatory matters by partners Laura Ferrell and Jennifer Tian. The support of the associates like Ethan Cramer Gibbs and Nicholas Sun was instrumental in the successful closing of the fund.
—
Read More Health & Wellness News ; US News